| Primary |
| Drug Use For Unknown Indication |
24.4% |
| Bronchitis |
9.5% |
| Hypertension |
8.3% |
| Lung Disorder |
8.2% |
| Product Used For Unknown Indication |
8.1% |
| Pneumonia |
7.1% |
| Urinary Tract Infection |
4.8% |
| Chronic Obstructive Pulmonary Disease |
3.3% |
| Sinusitis |
2.6% |
| Pain |
2.5% |
| Drug Exposure During Pregnancy |
2.4% |
| Atrial Fibrillation |
2.3% |
| Prophylaxis |
2.3% |
| Pyrexia |
2.3% |
| Respiratory Tract Infection |
2.3% |
| Lung Infection |
2.2% |
| Infection |
2.1% |
| Influenza |
1.9% |
| Prostatitis |
1.9% |
| Cough |
1.4% |
|
| Tendonitis |
17.7% |
| Tendon Rupture |
9.5% |
| Thrombocytopenia |
8.2% |
| Vomiting |
6.5% |
| Tendon Pain |
5.8% |
| Renal Failure Acute |
4.8% |
| Toxic Skin Eruption |
4.8% |
| Tachycardia |
4.4% |
| Transaminases Increased |
4.4% |
| Tremor |
4.1% |
| International Normalised Ratio Increased |
3.7% |
| Rash Maculo-papular |
3.7% |
| Tendon Disorder |
3.4% |
| Renal Failure |
3.1% |
| Toxic Epidermal Necrolysis |
3.1% |
| Hypersensitivity |
2.7% |
| Pruritus |
2.7% |
| Shock |
2.7% |
| Cholestasis |
2.4% |
| Myalgia |
2.4% |
|
| Secondary |
| Drug Use For Unknown Indication |
26.8% |
| Product Used For Unknown Indication |
15.0% |
| Hypertension |
7.0% |
| Lung Disorder |
4.7% |
| Bronchitis |
4.2% |
| Lung Infection |
4.0% |
| Pneumonia |
3.5% |
| Pyrexia |
3.4% |
| Drug Exposure During Pregnancy |
3.2% |
| Infection |
3.2% |
| Pain |
3.2% |
| Prophylaxis |
2.7% |
| Influenza Like Illness |
2.6% |
| Rash |
2.5% |
| Chronic Obstructive Pulmonary Disease |
2.4% |
| Febrile Infection |
2.4% |
| Thrombosis Prophylaxis |
2.4% |
| Urinary Tract Infection |
2.3% |
| Atrial Fibrillation |
2.2% |
| Sinusitis |
2.2% |
|
| Thrombocytopenia |
10.9% |
| Renal Failure Acute |
10.0% |
| Transaminases Increased |
8.7% |
| Toxic Skin Eruption |
6.5% |
| Tendon Pain |
5.9% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
5.6% |
| Urticaria |
4.7% |
| Vomiting |
4.7% |
| Neutropenia |
4.4% |
| Rash Maculo-papular |
4.4% |
| Toxic Epidermal Necrolysis |
4.4% |
| Cytolytic Hepatitis |
4.0% |
| Tendonitis |
4.0% |
| Jaundice |
3.7% |
| Stevens-johnson Syndrome |
3.4% |
| Tendon Rupture |
3.4% |
| Pruritus |
3.1% |
| Pancytopenia |
2.8% |
| Renal Failure |
2.8% |
| Agranulocytosis |
2.5% |
|
| Concomitant |
| Product Used For Unknown Indication |
20.7% |
| Drug Use For Unknown Indication |
19.0% |
| Prophylaxis |
8.6% |
| Hypertension |
5.3% |
| Infection |
4.9% |
| Pain |
4.9% |
| Pneumonia |
4.3% |
| Breast Cancer |
3.4% |
| Sepsis |
2.8% |
| Rheumatoid Arthritis |
2.8% |
| Multiple Myeloma |
2.7% |
| Prophylaxis Against Renal Transplant Rejection |
2.5% |
| Nausea |
2.4% |
| Premedication |
2.4% |
| Thrombosis Prophylaxis |
2.4% |
| Acute Myeloid Leukaemia |
2.2% |
| Infection Prophylaxis |
2.2% |
| Chronic Lymphocytic Leukaemia |
2.1% |
| Chronic Obstructive Pulmonary Disease |
2.1% |
| Lung Infection |
2.1% |
|
| Thrombocytopenia |
9.6% |
| Renal Failure Acute |
7.8% |
| Vomiting |
7.8% |
| Sepsis |
7.3% |
| Pyrexia |
6.9% |
| Pneumonia |
6.4% |
| Respiratory Failure |
6.4% |
| Urticaria |
6.0% |
| Renal Failure |
4.6% |
| Septic Shock |
4.6% |
| Multi-organ Failure |
4.1% |
| Neutropenia |
4.1% |
| Tremor |
4.1% |
| Pulmonary Embolism |
3.7% |
| Tachycardia |
3.2% |
| Urinary Tract Infection |
3.2% |
| Nausea |
2.8% |
| Pancytopenia |
2.8% |
| Dyspnoea |
2.3% |
| Eosinophilia |
2.3% |
|
| Interacting |
| Hypertension |
13.4% |
| Atrial Fibrillation |
12.3% |
| Drug Use For Unknown Indication |
11.7% |
| Urinary Tract Infection |
11.2% |
| Lung Disorder |
5.6% |
| Type 2 Diabetes Mellitus |
5.6% |
| Prophylaxis |
5.0% |
| Urosepsis |
4.5% |
| Bacterial Pyelonephritis |
3.4% |
| Ischaemic Heart Disease Prophylaxis |
3.4% |
| Multiple Myeloma |
3.4% |
| Product Used For Unknown Indication |
2.8% |
| Cardiac Failure |
2.2% |
| Diarrhoea |
2.2% |
| Gout |
2.2% |
| Helicobacter Infection |
2.2% |
| Iron Deficiency Anaemia |
2.2% |
| Myocardial Infarction |
2.2% |
| Phantom Pain |
2.2% |
| Pneumonia |
2.2% |
|
| Drug Interaction |
19.4% |
| Clostridium Difficile Colitis |
16.1% |
| Torsade De Pointes |
9.7% |
| Ventricular Tachycardia |
9.7% |
| Lung Disorder |
6.5% |
| Traumatic Haematoma |
6.5% |
| Vessel Puncture Site Haemorrhage |
6.5% |
| Extrapyramidal Disorder |
3.2% |
| Intra-abdominal Haemorrhage |
3.2% |
| Multiple Myeloma |
3.2% |
| Muscle Haemorrhage |
3.2% |
| Overdose |
3.2% |
| Pancytopenia |
3.2% |
| Renal Failure Acute |
3.2% |
| Ventricular Extrasystoles |
3.2% |
|
